This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Pinnacle West's Unit Applies for Utility Bills Reduction
by Sanhita Banerjee
Pinnacle West (PNW) unit seeks approval to pass on TCJA savings to users.
Why Exelon (EXC) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Exelon (EXC) have what it takes? Let's find out.
Why Exelon (EXC) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Exelon (EXC) have what it takes? Let's find out.
Why Is Exelon (EXC) Up 1.4% Since Last Earnings Report?
by Zacks Equity Research
Exelon (EXC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Zacks Analyst Blog Highlights: Comcast, Deere and Exelon
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Comcast, Deere and Exelon
Top Analyst Reports for Comcast, Deere & Exelon
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Comcast (CMCSA), Deere (DE) and Exelon (EXC).
Eversource Energy (ES) Misses on Q4 Earnings, Beats Revenues
by Zacks Equity Research
Although Eversource Energy's (ES) fourth-quarter earnings and revenues lag estimates, the company distributes higher volumes of natural gas in the reported quarter.
Retail Unit Helps Southern Company (SO) Beat Q4 Earnings
by Nilanjan Choudhury
Southern Company's (SO) total retail sales edged up 0.7%, with residential sales improving 3.7%.
Exelon (EXC) Posts In-Line Q4 Earnings, Beats on Revenues
by Zacks Equity Research
Exelon's (EXC) fourth-quarter earnings are in line with the Zacks Consensus Estimate. Its total revenues are higher year over year due to strong contribution from Utility and Generation businesses.
Exelon (EXC) Q4 Earnings Match Estimates
by Zacks Equity Research
Exelon (EXC) delivered earnings and revenue surprises of 0.00% and 22.04%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Exelon (EXC) to Report Q4 Earnings: Is a Beat in Store?
by Zacks Equity Research
Exelon (EXC) is expected to surpass estimates when it reports fourth-quarter earnings on Feb 8, 2019, courtesy of new rates and cost-management initiatives.
Exelon (EXC) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Exelon (EXC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NextEra Energy's (NEE) Q4 Earnings & Revenues Lag Estimates
by Zacks Equity Research
Although NextEra Energy (NEE) misses Q4 earnings and revenue estimates, it is on course to add more renewable assets in its generation portfolio.
Exelon Unit Gets Approval to Increase Gas Rates in Maryland
by Zacks Equity Research
Exelon (EXC) unit gets approval to recoup capital investment and increase natural gas rates for its Maryland customers by $5.40 per month.
Should Franklin LibertyQ U.S. Equity ETF (FLQL) Be on Your Investing Radar?
by Sweta Killa
Style Box ETF report for FLQL
Here's Why Exelon (EXC) Is Profitable for Your Portfolio
by Zacks Equity Research
Exelon (EXC) to provide investors with better returns, courtesy of five factors.
FirstEnergy (FE) to Lower Customer Bill Through Rate Review
by Zacks Equity Research
FirstEnergy (FE) to offer second reduction in electric rates to West Virginia customers since September 2018.
Are Investors Undervaluing Exelon (EXC) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
The Zacks Analyst Blog Highlights: Intuitive Surgical, HCA Healthcare, Exelon, 3M and Micron
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Intuitive Surgical, HCA Healthcare, Exelon, 3M and Micron
EXC vs. IDA: Which Stock Is the Better Value Option?
by Zacks Equity Research
EXC vs. IDA: Which Stock Is the Better Value Option?
Top Research Reports for Intuitive Surgical, HCA Healthcare & Exelon
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Intuitive Surgical (ISRG), HCA Healthcare (HCA) and Exelon (EXC).
Zacks.com featured highlights include: ArcBest, Zions, Covenant Transportation, Seaspan and Exelon
by Zacks Equity Research
Zacks.com featured highlights include: ArcBest, Zions, Covenant Transportation, Seaspan and Exelon
5 Value Picks With Strikingly Low EV/EBITDA Ratios
by Anindya Barman
We have screened value stocks based on EV/EBITDA ratio that offers a clearer picture of a company's valuation and earnings potential.
Top Stock Reports for Eli Lilly, Anthem & BlackRock
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly (LLY), Anthem (ANTM) and BlackRock (BLK).
Exelon's (EXC) Unit Gets Consent to Reduce Rates in 2019
by Zacks Equity Research
Exelon's unit, ComEd receives approval from The Illinois Commerce Commission to lower delivery charges from January 2019.